VICENTE
ESTRADA PÉREZ
Profesor asociado de Ciencias de la Salud
Publicaciones (211) Publicaciones en las que ha participado algún/a investigador/a
2024
-
Incidence of sexually transmitted infections and screening models among pre-exposure prophylaxis users
Enfermedades Infecciosas y Microbiologia Clinica
-
Mpox, herpes, and enteroviruses: Differential diagnosis
Journal of Medical Virology
2023
-
Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19
Infectious Diseases Now, Vol. 53, Núm. 7
-
Differences in the inflammatory response among hospitalized patients with distinct variants of SARS-CoV-2
Frontiers in Immunology, Vol. 14
-
Faster lung function decline in people living with HIV despite adequate treatment: A longitudinal matched cohort study
Thorax, Vol. 78, Núm. 6, pp. 535-542
-
Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry
Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78
-
Impact of the COVID-19 pandemic on the mental health of the general population and health care workers
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 2, pp. 125-143
-
Monitoring monkeypox virus in saliva and air samples in Spain: a cross-sectional study
The Lancet Microbe, Vol. 4, Núm. 1, pp. e21-e28
-
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry
Scientific Reports, Vol. 13, Núm. 1
-
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis
Frontiers in Cellular and Infection Microbiology, Vol. 13
-
Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV
Scientific Reports, Vol. 13, Núm. 1
-
Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors
Biomedicines, Vol. 11, Núm. 4
-
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 11, pp. 2696-2701
-
TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial
Thorax, Vol. 78, Núm. 8, pp. 816-824
-
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 76, Núm. 3, pp. e116-e125
-
Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort
Journal of Clinical Medicine, Vol. 12, Núm. 3
2022
-
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry
International Journal of Clinical Practice, Vol. 2022
-
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)
Open Forum Infectious Diseases
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry
Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 761-775